Publication History

Footnotes

Conflicts of interest These authors disclose the following: Joseph A. Murray has received grant support from the National Institutes of Health, Alba Therapeutics, the Oberkotter Foundation (Oberkotter #1), and the Broad Medical Research Program at Crohn's & Colitis Foundation of America (342367), has served on the advisory boards of Celimmune, LLC, AMAG Pharmaceuticals, Entera Health, Inc, Sonomaceuticals, LLC, BioLineRx, GlaxoSmithKline, Genentech, and Glenmark Pharmaceuticals Ltd, has served as a consultant to Boehringer Ingelheim, is a patent holder with Miomics, and holds equity options in Torax; Ciarán P. Kelly has received grant support from the National Institutes of Health, has served on the advisory boards of Alvine Pharmaceuticals and Alba Therapeutics, and has served as a consultant for Cour Pharmaceuticals; Peter H. R. Green has provided scientific advice to Alvine Pharmaceuticals, Inc, and has served on the advisory board of ImmusanT; Annette Marcantonio and Daniel C. Adelman are former employees of Alvine Pharmaceuticals, Inc; and Markku Maki has received grant support from Competitive State Research Financing of the Expert Responsibility Area of the Tampere University Hospital (9T040) and Tekes (The Finnish Funding Agency for Innovation 658/31/2015), has served on the advisory boards of the Finnish Celiac Society, Alvine Pharmaceuticals, Inc, ImmusanT, Inc, BioLineRx, Ltd, Celimmune, LLC, and Trivitron Ltd, has served as a consultant to FinnMedi Oy Ltd, GSK Vaccines, Inc, and Glenmark Pharmaceuticals Ltd, is an inventor of the patent “Methods and Means for Detecting Gluten-Induced Diseases,” USA patent number 7,361,480-USA, European patent number 1390753, which has been commercialized by FinnMedi Oy Ltd and licensed to Labsystems Diagnostics Ltd. The remaining author discloses no conflicts.

Funding This study was sponsored by Alvine Pharmaceuticals, Inc, San Carlos, CA. The study sponsor was involved in the design, initiation, supervision, and interpretation of results.